Arslan F, Bongartz L, ten Berg JM, Jukema JW, Appelman Y, Liem AH, de Winter RJ, van ’t Hof AWJ, Damman P (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group. Netherlands Heart J 26:417–421

Engstrøm T, Kelbæk H, Helqvist S et al (2015) Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. The Lancet 386:665–671

Article  Google Scholar 

Cui K, Zhang D, Lyu S, Song X, Yuan F, Xu F, Zhang M (2018) Meta-analysis comparing percutaneous coronary revascularization using drug-eluting stent versus coronary artery bypass grafting in patients with left ventricular systolic dysfunction. Am J Cardiol 122:1670–1676

Article  PubMed  Google Scholar 

Goel SS, Shishehbor MH (2013) Strategies for multivessel revascularization in patients with diabetes. Cardiol Rev 29:2375–2384

Google Scholar 

Serruys PW, Morice M-C, Kappetein AP et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972

Article  PubMed  CAS  Google Scholar 

Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045–1057

Article  PubMed  CAS  Google Scholar 

Diab S, Arazi M, Sternik L, Raanani E, Kachel E, Grosman-Rimon L, Shalabi A, Amir O, Carasso S (2021) Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes. J Cardiothorac Surg 16:139

Article  PubMed  PubMed Central  Google Scholar 

Lawton JS, Tamis-Holland JE, Bangalore S et al (2022) 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:E18–E114

PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 44:3720–3826

Article  PubMed  CAS  Google Scholar 

Gershlick AH, Banning AS, Parker E et al (2019) Long-term follow-up of complete versus lesion-only revascularization in STEMI and multivessel disease: The CvLPRIT Trial. J Am Coll Cardiol 74:3083–3094

Article  PubMed  Google Scholar 

Pavasini R, Biscaglia S, Barbato E et al (2020) Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J 41:4103–4110

Article  PubMed  CAS  Google Scholar 

Hansson EC, Rexius H, Dellborg M, Albertsson P, Jeppsson A (2014) Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor. Eur J Cardiothorac Surg 46:699–705

Article  PubMed  Google Scholar 

Held C, Senblad N, Bassand JP et al (2011) Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) Trial. J Am Coll Cardiol 57:672–684

Article  PubMed  CAS  Google Scholar 

Hansson EC, Jidéus L, Åberg B et al (2016) Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 37:189–197

Article  PubMed  Google Scholar